コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 oma-associated herpesvirus (KSHV) is a human oncogenic virus.
2 and showed that it harbors an infectious and oncogenic virus.
3 (HVS) is a T-cell-specific transforming and oncogenic virus.
4 ween this process and tumorigenesis by other oncogenic viruses.
5 c microRNA miR-155 is upregulated by several oncogenic viruses.
6 enes (TSGs) in cancers and may be induced by oncogenic viruses.
7 tumor risks, but most tumors are related to oncogenic viruses.
8 han might be predicted by analogy with other oncogenic viruses.
9 aviruses (HPVs) and polyomaviruses-including oncogenic viruses.
10 ence of HIV, in addition to coinfection with oncogenic viruses.
11 concurrent infection with many, potentially oncogenic, viruses.
14 's sarcoma-associated herpesvirus (KSHV), an oncogenic virus also known as human herpesvirus 8, encod
15 including Epstein-Barr virus (EBV) - a human oncogenic virus and essential trigger of multiple sclero
16 n of cell telomerase/telomere function by an oncogenic virus and suggest its potential role in both n
17 oma-associated herpesvirus (KSHV) is a human oncogenic virus and the causative agent of Kaposi's sarc
18 sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the causative agent of potentially f
19 sarcoma-associated herpesvirus (KSHV) is an oncogenic virus and the culprit behind the human disease
20 rr virus (EBV) is the first identified human oncogenic virus and the founding member of the gammaherp
21 cer results from a complex interplay between oncogenic viruses and cervical tar exposures through tar
25 ty, possibly leading to a loss of control of oncogenic viruses and reduced tumor immunosurveillance.
26 lymphoid malignancies or cancers induced by oncogenic viruses are able to gradually overcome the imm
28 dies, immune adjuvants, and vaccines against oncogenic viruses are now well-established cancer therap
32 Human papillomavirus (HPV) is a significant oncogenic virus, but the innate immune response to HPV i
34 er hand, EBV represents the first identified oncogenic virus, capable of causing >=7 different types
37 ofactors related to immunodeficiency such as oncogenic viruses, chronic antigenic stimulation, and cy
38 First, AMV was used to demonstrate that all oncogenic viruses did not contain a single cancer-causin
40 ted with immunodeficiency and coinfection by oncogenic virus (Epstein-Barr virus, Kaposi sarcoma herp
41 g important and illustrative examples of how oncogenic viruses evade the immune system, we aim to she
43 Signatures for DNA and RNA viruses including oncogenic viruses, gram positive and negative bacteria,
46 man papillomavirus type 16 (HPV16) and other oncogenic viruses have been reported to deregulate immun
48 lts illustrate a novel mechanism by which an oncogenic virus hijacks a key metabolic pathway to promo
49 lts illustrate a novel mechanism by which an oncogenic virus hijacks a key metabolic pathway to promo
50 ulatory networks, infection with potentially oncogenic viruses (human herpesvirus-8 [HHV-8], Epstein-
51 and function are regulated by KSHV or other oncogenic viruses in the tumor microenvironment to promo
54 tors include tobacco use, alcohol abuse, and oncogenic viruses, including human papillomavirus and Ep
55 rs and tumor cell lines induced by the small oncogenic viruses, including the high-risk human papillo
56 ITAM-bearing proteins are also found in many oncogenic viruses, including the mouse mammary tumor vir
58 the contributions of immune dysfunction and oncogenic virus infection to pathogenesis of AIDS-associ
59 nancy that is closely associated with one of oncogenic viruses infection, Kaposi's sarcoma-associated
63 ociated herpesvirus (KSHV), one of the human oncogenic viruses, is the principal causative agent.
64 oci that are highly related to two exogenous oncogenic viruses, jaagsiekte sheep retrovirus (JSRV) an
66 portant roles in host-pathogen interactions; oncogenic viruses like Kaposi's sarcoma herpesvirus (KSH
67 's sarcoma-associated herpesvirus (KSHV), an oncogenic virus linked to the development of Kaposi's sa
69 gh incidence of malignancies associated with oncogenic viruses make Brazil an important site for clin
70 (ARLs) are frequently associated with known oncogenic viruses, many cases contain no known transform
72 growth role for a tumor-suppressive miRNA in oncogenic-virus-mediated transformation, highlighting th
73 tified in this study suggest ways that these oncogenic viruses modulate the tumor microenvironment an
75 sing epigenetic drugs in tumors positive for oncogenic viruses or as therapeutic combinations with on
76 trolled, yet several pathogens, most notably oncogenic viruses, perturb this process leading to incre
77 ssociated herpesvirus (KSHV) is an important oncogenic virus previously shown to be neurotropic, but
78 aps, one of the most common themes among the oncogenic viruses rests in the ability of one or more of
79 This may be an important mechanism for an oncogenic virus such as HTLV-1 to stop the host at the G
81 udy investigates the presence of potentially oncogenic viruses such as SV40, JCV, BKV and EBV in pati
83 agents (methylcholanthrene, thioacetamide), oncogenic viruses (SV40, HPV-16), and genetic manipulati
84 sarcoma associated herpesvirus (KSHV), is an oncogenic virus that can cause Kaposi's sarcoma (KS).
85 sease virus (MDV) is a highly infectious and oncogenic virus that can induce severe T cell lymphomas
87 Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of diff
89 si sarcoma-associated herpesvirus (KSHV), an oncogenic virus that promotes the development of Kaposi
90 ells transformed by chemical carcinogens and oncogenic viruses, the localization of the cph locus on
91 e for stimulating or inhibiting a coexisting oncogenic virus via viral interference or immune cross-r
92 ering activities involving heavy exposure to oncogenic viruses were strongly associated with these tu
93 oma-associated herpesvirus (KSHV) is a human oncogenic virus, which maintains the persistent infectio
94 de profound insights into the interaction of oncogenic viruses with IRF4 in the development of hemato